EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,649,942 | -39.7% | 294,860 | -25.7% | 0.00% | -50.0% |
| Q2 2023 | $7,716,689 | +74.8% | 396,949 | +155.1% | 0.00% | +100.0% |
| Q1 2023 | $4,414,485 | -13.4% | 155,604 | -10.7% | 0.00% | 0.0% |
| Q4 2022 | $5,094,818 | -39.9% | 174,301 | -45.7% | 0.00% | -50.0% |
| Q3 2022 | $8,475,000 | +192.0% | 320,761 | +391.1% | 0.00% | +100.0% |
| Q2 2022 | $2,902,000 | +1.5% | 65,320 | +13.1% | 0.00% | – |
| Q1 2022 | $2,858,000 | +114.9% | 57,761 | +121.3% | 0.00% | – |
| Q4 2021 | $1,330,000 | -54.0% | 26,105 | -49.6% | 0.00% | -100.0% |
| Q3 2021 | $2,889,000 | +36.3% | 51,794 | +4.6% | 0.00% | – |
| Q2 2021 | $2,119,000 | -43.3% | 49,516 | -44.7% | 0.00% | -100.0% |
| Q1 2021 | $3,739,000 | -65.8% | 89,577 | -61.9% | 0.00% | -66.7% |
| Q4 2020 | $10,944,000 | -23.7% | 234,999 | -30.4% | 0.00% | -25.0% |
| Q3 2020 | $14,348,000 | +52.7% | 337,756 | +72.4% | 0.00% | +33.3% |
| Q2 2020 | $9,398,000 | +1425.6% | 195,878 | +1362.5% | 0.00% | – |
| Q1 2020 | $616,000 | +2.5% | 13,393 | +34.0% | 0.00% | – |
| Q4 2019 | $601,000 | -81.7% | 9,996 | -82.8% | 0.00% | -100.0% |
| Q3 2019 | $3,280,000 | -8.6% | 57,997 | -10.0% | 0.00% | 0.0% |
| Q2 2019 | $3,588,000 | -23.3% | 64,448 | -30.4% | 0.00% | -50.0% |
| Q1 2019 | $4,675,000 | +157.3% | 92,604 | +105.4% | 0.00% | +100.0% |
| Q4 2018 | $1,817,000 | -92.3% | 45,085 | -86.7% | 0.00% | -90.9% |
| Q3 2018 | $23,519,000 | +4.0% | 339,239 | +13.5% | 0.01% | +10.0% |
| Q2 2018 | $22,623,000 | +8.1% | 299,006 | -24.7% | 0.01% | -9.1% |
| Q1 2018 | $20,933,000 | +275.1% | 397,296 | +280.3% | 0.01% | +266.7% |
| Q4 2017 | $5,580,000 | +239.0% | 104,469 | +278.5% | 0.00% | +50.0% |
| Q3 2017 | $1,646,000 | -51.8% | 27,600 | -36.3% | 0.00% | -33.3% |
| Q2 2017 | $3,417,000 | -28.3% | 43,304 | -24.6% | 0.00% | -25.0% |
| Q1 2017 | $4,765,000 | -57.9% | 57,464 | -59.7% | 0.00% | -63.6% |
| Q4 2016 | $11,324,000 | +9.5% | 142,735 | -3.4% | 0.01% | +10.0% |
| Q3 2016 | $10,344,000 | +10.2% | 147,770 | -38.9% | 0.01% | 0.0% |
| Q2 2016 | $9,385,000 | +2200.2% | 241,959 | +2300.9% | 0.01% | +900.0% |
| Q1 2016 | $408,000 | -79.3% | 10,078 | -54.6% | 0.00% | -50.0% |
| Q4 2015 | $1,969,000 | +432.2% | 22,202 | +343.8% | 0.00% | – |
| Q3 2015 | $370,000 | -83.8% | 5,003 | -82.3% | 0.00% | -100.0% |
| Q2 2015 | $2,288,000 | +753.7% | 28,295 | +342.0% | 0.00% | – |
| Q1 2015 | $268,000 | – | 6,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
| Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
| GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
| SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
| BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
| Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
| Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
| Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
| Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
| SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |